Mycobacterium tuberculosis PPE2 protein-derived peptide ameliorates DSS-induced colitis by depleting mast cells
Pooja Kushwaha, Sangita Mukhopadhyay · 2026
Read Mycobacterium tuberculosis PPE2 protein-derived peptide ameliorates DSS-induced colitis by depleting mast cells by Pooja Kushwaha, Sangita Mukhopadhyay (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427529.txt.
Description
Pooja Kushwaha and Sangita Mukhopadhyay show a tuberculosis protein fragment easing experimental colitis by removing mast cells in a 2026 mouse study. A peptide derived from the Mycobacterium tuberculosis PPE2 protein improved dextran sulfate induced colitis across weight loss, disease activity score, colon length, and the inflammation marker myeloperoxidase. Treatment lowered inflammatory cytokines, raised gene levels for the gut barrier proteins occludin, claudin-1, and ZO-1, and preserved barrier function.
Transferring mast cells back into treated mice restored disease, proving those cells are the peptide's main target, and combining the peptide with mesalazine performed better in their exploration. Dual targeting could strengthen inflammatory bowel disease therapy. Gut wall leaks let germs and their waste slip through, so a drug that seals the wall and cools the flare strikes at the root of the ill state.
Catalog record
| CREATOR | Pooja Kushwaha, Sangita Mukhopadhyay |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78212 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |